Medifast appoints Jonathan B. MacKenzie as Chief Accounting Officer effective Sept 13, 2021

MEDIFAST INC

MacKenzie succeeds James P. Maloney, who remains CFO; Maloney ceases as Interim CAO.
Annual base salary of $280,000; target annual bonus of 40% of base salary, prorated for 2021.
Cash sign-on bonus of $20,000; equity sign-on award of $25,000 in time-based deferred shares vesting ratably over 3 years.
MacKenzie previously a Managing Director at PwC Risk Assurance; no family relationships or arrangements with other officers.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Jonathan B. MacKenzie

Chief Accounting Officer

MED · MEDIFAST INC

Effective: 2021-09-13
Filed: September 13, 2021, 7:59 PM ET

Effective as of September 13, 2021, the Board of Directors of Medifast, Inc. (the “Company”) appointed Jonathan B. MacKenzie to serve as Chief Accounting Officer of the Company.

Role change

James P. Maloney

Interim Chief Accounting Officer

MED · MEDIFAST INC

Effective: 2021-09-13
Successor: Jonathan B. MacKenzie
Filed: September 13, 2021, 7:59 PM ET

Mr. MacKenzie succeeds James P. Maloney, who will cease to serve as the Company’s Interim Chief Accounting Officer upon the effectiveness of Mr. MacKenzie’s employment.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Jonathan B. MacKenzie was appointed as Chief Accounting Officer at MEDIFAST INC.

Action: appointed
Role: Chief Accounting Officer

Exact text from the filing

Effective as of September 13, 2021, the Board of Directors of Medifast, Inc. (the “Company”) appointed Jonathan B. MacKenzie to serve as Chief Accounting Officer of the Company.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

James P. Maloney changed role as Interim Chief Accounting Officer at MEDIFAST INC.

Action: ceased
Role: Interim Chief Accounting Officer

Exact text from the filing

Mr. MacKenzie succeeds James P. Maloney, who will cease to serve as the Company’s Interim Chief Accounting Officer upon the effectiveness of Mr. MacKenzie’s employment.

View on SEC.gov

MEDIFAST INC filing history →

Source: SEC EDGAR

accession 0001104659-21-115113

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.